Schedule 13D ownership disclosure
ESPERION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 29664W105
Event date: 2014-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-070902
- Form type
- SC 13D
- Filer
- Esperion Therapeutics, Inc.
- CIK
- CIK 1434868
- Filed
- Nov 25, 2014
- Reporting period
- Nov 17, 2014
- Description
- Schedule 13D beneficial ownership